Copyright 2000 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2000
Amiodarone has become an important drug for the treatment of supraventricular and ventricular arrhythmias, in short-term inpatient and outpatient settings. It may also have a role in affecting outcome in patients at high risk for arrhythmic events and sudden death; its place among available therapies is being established in clinical trials.
Goldschlager N, Epstein AE, Naccarelli G, Olshansky B, Singh B, . Practical Guidelines for Clinicians Who Treat Patients With Amiodarone. Arch Intern Med. 2000;160(12):1741-1748. doi:10.1001/archinte.160.12.1741